Tumor invasiveness also affected the diagnostic performance of AFP, PIVKA-II, and OPN, which had higher AUCs in patients with diffuse-type HCC than in those with non-diffuse HCC. This evidence concerns the gene SPP1 and hepatocellular carcinoma.